-+ 0.00%
-+ 0.00%
-+ 0.00%

Reported May 14, 2025: TransCode Therapeutics Q1 EPS $(2.51) Misses $(2.00) Estimate

Benzinga·05/15/2025 12:56:31
Listen to the news
TransCode Therapeutics (NASDAQ:RNAZ) reported quarterly losses of $(2.51) per share which missed the analyst consensus estimate of $(2.00) by 25.5 percent. This is a 88.24 percent increase over losses of $(21.35) per share from the same period last year.